1. Home
  2. HOWL vs ALTS Comparison

HOWL vs ALTS Comparison

Compare HOWL & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • ALTS
  • Stock Information
  • Founded
  • HOWL 2017
  • ALTS 1976
  • Country
  • HOWL United States
  • ALTS United States
  • Employees
  • HOWL N/A
  • ALTS N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • ALTS
  • Sector
  • HOWL Health Care
  • ALTS
  • Exchange
  • HOWL Nasdaq
  • ALTS NYSE
  • Market Cap
  • HOWL 53.4M
  • ALTS 159.4M
  • IPO Year
  • HOWL 2021
  • ALTS N/A
  • Fundamental
  • Price
  • HOWL $1.25
  • ALTS $7.88
  • Analyst Decision
  • HOWL Strong Buy
  • ALTS
  • Analyst Count
  • HOWL 3
  • ALTS 0
  • Target Price
  • HOWL $8.33
  • ALTS N/A
  • AVG Volume (30 Days)
  • HOWL 549.7K
  • ALTS 298.1K
  • Earning Date
  • HOWL 08-07-2025
  • ALTS 08-18-2025
  • Dividend Yield
  • HOWL N/A
  • ALTS N/A
  • EPS Growth
  • HOWL N/A
  • ALTS N/A
  • EPS
  • HOWL N/A
  • ALTS N/A
  • Revenue
  • HOWL $1,143,000.00
  • ALTS $18,046,000.00
  • Revenue This Year
  • HOWL N/A
  • ALTS $185.91
  • Revenue Next Year
  • HOWL N/A
  • ALTS $64.93
  • P/E Ratio
  • HOWL N/A
  • ALTS N/A
  • Revenue Growth
  • HOWL N/A
  • ALTS N/A
  • 52 Week Low
  • HOWL $0.60
  • ALTS $1.29
  • 52 Week High
  • HOWL $4.18
  • ALTS $10.95
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 45.36
  • ALTS 47.13
  • Support Level
  • HOWL $1.03
  • ALTS $7.06
  • Resistance Level
  • HOWL $1.10
  • ALTS $8.38
  • Average True Range (ATR)
  • HOWL 0.07
  • ALTS 0.91
  • MACD
  • HOWL -0.02
  • ALTS -0.17
  • Stochastic Oscillator
  • HOWL 22.81
  • ALTS 33.51

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.

Share on Social Networks: